← SynDRA
M-344
SynDRA canonical compound SYN0079160 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | HDAC8 |
| Mechanism of action | HDAC inhibitor |
All known targets
Mechanisms of action (all sources)
- histone deacetylase inhibitor
Cross-references
Synonyms
- 4-(dimethylamino)-n-[7-(hydroxyamino)-7-oxoheptyl]benzamide
- 4-(dimethylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)benzamide
- Histone Deacetylase Inhibitor III
- N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide
- 4-Dimethylamino-N-(6-hydroxycarbamoylhexyl)benzamide
- CHEBI:125562
- 7-{[4-(DIMETHYLAMINO)PHENYL]FORMAMIDO}-N-HYDROXYHEPTANAMIDE
- 7-((4-(dimethylamino)phenyl)formamido)-N-hydroxyheptanamide
- RefChem:97437
- 4-(dimethylamino)-NHAOBzNH2
- m344
- MFCD03453554
- J8W4VF5ZEJ
- D 237;MS 344
- 4-DIMETHYLAMINO-N-(6-HYDROXYCARBAMOYLHEXYL)-BENZAMIDE
- B3N
- UNII-J8W4VF5ZEJ
- MLS006011092
- SCHEMBL675763
- N-Hydroxy-7-(4-dimethylaminobenzoyl)-aminoheptanamide
- orb1306294
- 4-(Dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-benzamide
- GLXC-02057
- HMS3648E20
- HMS3656B08
- M344 (GMP)
- BDBM50082665
- HY-13506G
- NSC718169
- s2779
- AKOS022183358
- CCG-208693
- CS-1342
- NSC-718169
- M344, >=98% (HPLC), powder
- NCGC00263617-05
- NCGC00263617-10
- AS-71316
- D237
Look up M-344 in the interactive SynDRA portal →